Insights into the Biosynthesis of the Pyrrolamide Antibiotics Congocidine and Kikumycin.
Membres du jury:
- Pr Bertrand Aigle
- Dr Yanyan Li
- Pr Stéphanie Bury-Moné
- Dr Evi Stegmann
Abstract:
Congocidine and kikumycin, are pyrrolamide antibiotics characterized by the presence of pyrrole moieties linked by amide bonds. Congocidine, a minor groove DNA binder, is assembled from three precursors: 3-aminopropionamidine, 4-acetamidopyrrole-2-carboxylate, and guanidinoacetate. While the biosynthetic pathways for 3-aminopropionamidine and 4-acetamidopyrrole-2-carboxylate have been elucidated, the pathway leading to guanidinoacetate remains partially unresolved.
Our work has demonstrated that Cgc6 catalyzes the conversion of demethylcreatinine into guanidinoacetate. We now propose that Cgc7, a predicted structural analog of FemX, synthesizes demethylcreatinine using arginine and tRNA-Gly as substrates.
In parallel, the biosynthetic gene cluster for kikumycin has yet to be identified. Through genomic analysis, we discovered a candidate biosynthetic gene cluster in Streptomyces sp. TLI146, which we cloned and heterologously expressed in Streptomyces lividans and Streptomyces albus.
I will present my progress on elucidating the biosynthesis of these two pyrrolamide antibiotics, focusing on the Cgc7 enzymatic characterization and on the putative kikumycin gene cluster identification and characterization.
Choisissez le fuseau horaire
Le fuseau horaire de votre profil: